Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

Respiratory syncytial virus (RSV) is the most common cause of respiratory tract infections in both children and elderly people. In this study we evaluated the short- and long-term protective efficacy of a single intranasal (IN) immunization with a RSV vaccine formulation consisting of a codon-optimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, R., Latimer, L., Gerdts, V., Potter, A., van Drunen Littel-van den Hurk, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718833/
https://www.ncbi.nlm.nih.gov/pubmed/28825870
http://dx.doi.org/10.1080/21645515.2017.1349584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718833/
https://www.ncbi.nlm.nih.gov/pubmed/28825870
http://dx.doi.org/10.1080/21645515.2017.1349584

Ejemplares similares